Emergent BioSolutions Inc (NYSE:EBS)

21.29
Data as of 10:35am ET
 -0.3244 / -1.50%
Today’s Change
18.28
Today|||52-Week Range
28.48
-7.41%
Year-to-Date
Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog
Oct 20 / Zacks.com
Alnylam Jumps on Positive Patisiran Data from Phase II Study - Analyst Blog
Oct 14 / Zacks.com
Affymetrix-Ariosa Ink Supply Deal for Harmony Prenatal Test - Analyst Blog
Oct 20 / Zacks.com
Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4% - Tale of the Tape
Oct 14 / Zacks.com
Emergent BioSolutions (EBS) Jumps: Stock Moves Up 5.8% - Tale of the Tape
Oct 20 / Zacks.com
Alnylam Pharmaceuticals (ALNY) Jumps: Stock Rises 19% - Tale of the Tape
Oct 14 / Zacks.com
Infinity Pharmaceuticals' Duvelisib Fails in Mid-Stage Study - Analyst Blog
Oct 17 / Zacks.com
Prosensa Holding N.V. (RNA) in Focus: Stock up 8.5% - Tale of the Tape
Oct 14 / Zacks.com
Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog
Oct 17 / Zacks.com
Vical Incorporated (VICL) in Focus: Stock Soars 12% - Tale of the Tape
Oct 14 / Zacks.com
Gilead's Harvoni Receives Notice of Compliance from Canada - Analyst Blog
Oct 17 / Zacks.com
Exact Sciences (EXAS) Looks Strong: Stock Surges 35.8% - Tale of the Tape
Oct 13 / Zacks.com
What Falling Estimates & Price Mean for Enzo Biochem (ENZ) - Tale of the Tape
Oct 17 / Zacks.com
Nanosphere (NSPH) Soars: Stock Adds 26.6% in Session - Tale of the Tape
Oct 13 / Zacks.com
Alexion (ALXN) Seeks Japanese Approval for Asfotase Alfa - Analyst Blog
Oct 16 / Zacks.com
Weakness Seen in Momenta Pharmaceuticals (MNTA): Stock Tumbles 13.5% - Tale of the Ta...
Oct 13 / Zacks.com
Agios (AGIO) Rises on Expansion of Phase I Study on AG-221 - Analyst Blog
Oct 16 / Zacks.com
XOMA Starts Phase I Study on XOMA 358 for Hyperinsulinism - Analyst Blog
Oct 10 / Zacks.com
GW Pharmaceuticals Down on Disappointing Mid-Stage Data - Analyst Blog
Oct 15 / Zacks.com
Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of...
Oct 09 / Zacks.com
Novavax Begins Mid-Stage Study on RSV Vaccine in Elders - Analyst Blog
Oct 15 / Zacks.com
StemCells Starts Phase II Cervical Spinal Cord Injury Study - Analyst Blog
Oct 08 / Zacks.com
Alnylam Reveals Positive Data from its Pipeline Candidates - Analyst Blog
Oct 15 / Zacks.com
Emergent BioSolutions Revamps Business to Drive Earnings - Analyst Blog
Oct 08 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.